Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Ginter

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Acetylation of endogenous STAT proteinsTorsten Ginter, Thorsten Heinzel, Oliver H Krämer
JAK-STAT|January 14, 2014
STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesisChristian Kosan, Torsten Ginter, Thorsten Heinzel, et al.
Cytokine & Growth Factor Reviews|July 17, 2012
Acetylation modulates the STAT signaling codeMartin Wieczorek, Torsten Ginter, Peter Brand, et al.
Cytokine|May 17, 2021
STAT1 N-terminal domain discriminatively controls type I and type II IFN signalingAnja Göder, Torsten Ginter, Thorsten Heinzel, et al.
Cellular Signalling|January 22, 2013
Interferon alpha-armed nanoparticles trigger rapid and sustained STAT1-dependent anti-viral cellular responsesSibyll Pollok, Torsten Ginter, Katharina Günzel, et al.
Cellular Signalling|April 12, 2014
Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3Torsten Ginter, Jörg Fahrer, Ulrike Kröhnert, et al.
Oncotarget|February 1, 2012
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancerRoland H Stauber, Shirley K Knauer, Negusse Habtemichael, et al.
Cellular Signalling|March 20, 2012
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylationTorsten Ginter, Carolin Bier, Shirley K Knauer, et al.
Oncotarget|May 17, 2014
SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cellsSylvia Müller, Yuan Chen, Torsten Ginter, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Acetylation of endogenous STAT proteinsTorsten Ginter, Thorsten Heinzel, Oliver H Krämer
JAK-STAT|January 14, 2014
STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesisChristian Kosan, Torsten Ginter, Thorsten Heinzel, et al.
Cytokine & Growth Factor Reviews|July 17, 2012
Acetylation modulates the STAT signaling codeMartin Wieczorek, Torsten Ginter, Peter Brand, et al.
Cytokine|May 17, 2021
STAT1 N-terminal domain discriminatively controls type I and type II IFN signalingAnja Göder, Torsten Ginter, Thorsten Heinzel, et al.
Cellular Signalling|January 22, 2013
Interferon alpha-armed nanoparticles trigger rapid and sustained STAT1-dependent anti-viral cellular responsesSibyll Pollok, Torsten Ginter, Katharina Günzel, et al.
Cellular Signalling|April 12, 2014
Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3Torsten Ginter, Jörg Fahrer, Ulrike Kröhnert, et al.
Oncotarget|February 1, 2012
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancerRoland H Stauber, Shirley K Knauer, Negusse Habtemichael, et al.
Cellular Signalling|March 20, 2012
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylationTorsten Ginter, Carolin Bier, Shirley K Knauer, et al.
Oncotarget|May 17, 2014
SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cellsSylvia Müller, Yuan Chen, Torsten Ginter, et al.
Pageof 1